Merck

Merck Can Sue State For Outsourcing Vioxx Lawsuits
Pharmalot
Mon, 04/9/12 - 12:10 pm
Vioxx
lawsuits
Merck
Novo Nordisk says diabetes drug Victoza superior to Merck rival
Reuters
Sat, 04/7/12 - 11:56 am
Novo Nordisk
Victoza
Merck
Januvia
diabetes
Lpath: A Solid Pipeline With Good PPS
Seeking Alpha
Thu, 04/5/12 - 07:38 pm
Lpath
Pfizer
Merck
bioactive lipids
Vaccines alliance nears deal on cervical cancer shots
Reuters
Wed, 04/4/12 - 10:58 pm
vaccines
cervical cancer
Merck
Gardasil
HPV
GAVI
GSK
Pfizer: A Compelling Buy Candidate In 2012
Seeking Alpha
Wed, 04/4/12 - 10:56 pm
Pfizer
Abbott Laboratories
Bristol-Myers Squibb
GSK
Merck
Mead Johnson Nutrition
Merck: High Upside Expected From Vaccine
Seeking Alpha
Wed, 04/4/12 - 08:32 am
Merck
vaccines
shingles
Zostavax
herpes zoster
Merck: Now A Compelling 'Buy' Candidate
Seeking Alpha
Mon, 04/2/12 - 11:58 am
Merck
M&A
Bayer
GSK
Pfizer
Are Ariad's Options Dwindling?
Motley Fool
Sun, 04/1/12 - 12:35 pm
Ariad Pharmaceuticals
ridaforolimus
Merck
GSK
Votrient
Big Pharma Cozies Up to Biotech
Motley Fool
Sat, 03/31/12 - 12:20 pm
JNJ
Bayer
GSK
Eli Lilly
Merck
Biogen Idec
Abbott: Expect Strong Upside Movement, Both Pre And Post Research Division Spin-Off
Seeking Alpha
Thu, 03/29/12 - 11:58 am
Abbott Laboratories
JNJ
Merck
Pfizer
Sanofi
Watson Pharmaceuticals
Mixed Data on Merck's Vorapaxar
Yahoo/Zacks.com
Wed, 03/28/12 - 04:14 pm
Merck
Vorapaxar
TRA-2P
Merck says key Vytorin study cleared to continue
Reuters
Wed, 03/28/12 - 10:12 am
Merck
Vytorin
Merck Blood Thinner Stops Heart Attacks With Risk of Bleeding
Bloomberg
Sat, 03/24/12 - 11:47 am
Merck
blood thinner
Vorapaxar
Sanofi: A Good Long-Term Dividend Play?
Seeking Alpha
Fri, 03/23/12 - 12:42 pm
Sanofi
dividends
Merck
Pfizer
Research shows Merck's prospective flushing drug may have another use: preventing baldness
NJ.com
Thu, 03/22/12 - 11:29 am
Merck
baldness
Actelion
Next big cholesterol drugs in focus at meeting
Reuters
Thu, 03/22/12 - 11:28 am
cardiology
PCSK9 inhibitor
REGN 727
Amgen
Merck
Regeneron
Advisory Panel Pans Drug, Investors Shrug?
Motley Fool
Thu, 03/22/12 - 11:09 am
FDA
advisory panels
investors
ridaforolimus
Ariad Pharmaceuticals
Merck
The Best High Dividend Pharma Stocks
Motley Fool
Wed, 03/21/12 - 10:05 am
dividends
AstraZeneca
Pfizer
Sanofi
Merck
Eli Lilly
GSK
FDA panel does not recommend Taltorvic
Reuters
Wed, 03/21/12 - 10:03 am
soft tissue sarcomas
FDA
advisory panels
Taltorvic
Merck
Ariad Pharmaceuticals
EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data
TheStreet.com
Tue, 03/20/12 - 11:47 am
hepatitis C
EASL
Gilead
Bristol-Myers Squibb
Abbott Laboratories
Vertex
Merck

Pages